glp 1 through ro Beyond GLP1: modulating multiple nutrient-stimulated hormone pathways to reduce cardiovascular risk Cardiovascular, mortality, and kidney outcomes
Description
Collino M, Pini A, Mugelli N, Mastroianni R, Bani D, Fantozzi R, et al
30249-9/asset/ae163e52-907c-4c99-987f-36b369e8996a/main.assets/gr3.gif)
J.MavroudisI.BaloyannisI

[DOI] [PMC free article] [PubMed] [Google Scholar] 75.Campbell JN, et al

doi: 10.1016/j.cmet.2022.06.002

These are Novo Nordisks own studies

doi: 10.1097/MED.0000000000000616 135 LekiL
